bioRxivBioinformaticsPreprint
First computational design of Covid-19 coronavirus vaccine using lambda superstrings
Luis MartíneziD, Iker MalainaiD, David Salcines-CuevasiD, Hector L. Teran, Santos Alegre, Ildefonso M. De la FuenteiD, Elena González-LópeziD, Gonzalo Ocejo Vinyals, Carmen Alvarez-Domı́ngueziD
Abstract
In this work we have developed, by employing lambda superstrings, a map of candidate vaccines against SARS-CoV-2 with lengths between 9 and 200, based on estimations of the immunogenicity of the epitopes and the binding affinity of epitopes to MHC class I molecules using tools from the IEDB Analysis Resource, as well as the overall predictions obtained using the VaxiJen tool. We have synthesized one of the peptides, specifically the one of length 22, and we have carried out an immunogenicity assay and a cytokine assay, which has given positive results in both cases.
- Citations
- 1
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Multi-epitope vaccine design using an immunoinformatics approach for 2019 novel coronavirus (SARS-CoV-2)
- Towards the design of multiepitope-based peptide vaccine candidate against SARS-CoV-2
Hasanain Abdulhameed Odhar, Salam Waheed Ahjel, Suhad Sami Humadi·bioRxiv·Jul 7, 2020
- In silico approach for designing of a multi-epitope based vaccine against novel Coronavirus (SARS-COV-2)
Ratnadeep Saha, Prasad V.L.S. Burra·bioRxiv·Mar 31, 2020
- Epitope-based chimeric peptide vaccine design against S, M and E proteins of SARS-CoV-2 etiologic agent of global pandemic COVID-19: an in silico approach
M. S. Rahman, M. N. Hoque, … M. A. Hossain·PeerJPeer-reviewed·Jul 27, 2020
- Designing a multi-epitope peptide-based vaccine against SARS-CoV-2
Abhishek Singh, Mukesh Kumar Thakur, … Kailash Chandra·Scientific ReportsPeer-reviewed·Oct 1, 2020
- In silico design and characterization of multiepitopes vaccine for SARS-CoV2 from its Spike proteins
G. H. Kathwate·bioRxiv·Jun 3, 2020